Bluejay Diagnostics Inc Strategic Asset Allocation Index
Bluejay Diagnostics Inc strategic asset allocation index. Bluejay Diagnostics Inc (BJDX) has a Strategic Asset Allocation Index of 14.7% as of December 2022. Strategic assets (PP&E of $1.70 Million plus long-term investments of $-) total $1.70 Million, measured against net assets of $11.54 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See BJDX net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Bluejay Diagnostics Inc (2021–2022)
Strategic asset allocation index of Bluejay Diagnostics Inc from 2021 to 2022. This chart shows how Bluejay Diagnostics Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2021 to 2022. As of December 2022, the index stands at 14.7%, representing strategic assets of $1.70 Million against net assets of $11.54 Million USD. Check Bluejay Diagnostics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Bluejay Diagnostics Inc Strategic Asset Allocation Index by Year (2021–2022)
Bluejay Diagnostics Inc strategic asset allocation index by year from 2021 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Bluejay Diagnostics Inc from 2021 to 2022, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Bluejay Diagnostics Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 14.7% | $1.70 Million | $1.70 Million | $- | $11.54 Million | ▲ +13.1 pp |
| 2021 | 1.7% | $337.37K | $337.37K | $- | $20.38 Million | — |